A Multicenter, multicohort, open-label, single-arm per cohort, phase II study to assess the efficacy and safety of tabelecleucel in patients with EBV-associated diseases using an adaptive two-stage study design Meeting Abstract
| Authors: | Prockop, S.; Dinavahi, R.; Navarro, W.; Guzman-Becerra, N.; Sun, Y.; Gamelin, L. |
| Abstract Title: | A Multicenter, multicohort, open-label, single-arm per cohort, phase II study to assess the efficacy and safety of tabelecleucel in patients with EBV-associated diseases using an adaptive two-stage study design |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547206091 |
| DOI: | 10.1182/blood-2020-136075 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4 -- Source: Wos |
